Sector A – Z Index

artificial intelligence AI drug discovery

3

3D printing

A

adenovirus Algae Allergy Alzheimer’s Anti-aging Antibodies Antibody-drug conjugates Antimicrobial resistance Artificial intelligence asthma Autoimmune disease

B

bacteria Biofuels Bioinformatics Biomanufacturing Bioplastics Bioprinting Biosimilars Blood cancer Blood disorders Brain cancer breast cancer

C

Cancer CAR-T Cardiovascular disease Cell therapy Cell-based food Checkpoint Inhibitors chemotherapy Cosmetics Covid-19 CRISPR cystic fibrosis

D

dementia depression Diabetes Diagnostics digital technology DNA Drug delivery Drug development Drug discovery dystrophic epidermolysis bullosa

E

epigenetics Epilepsy Eye Disease

F

fermentation foodtech

G

Gastro-intestinal disease Gene editing Gene therapy genetic disorders genomics glioblastoma GMO GPCR graft versus host disease Gynecology

H

hearing loss Hemophilia hepatitis HIV Huntington’s disease

I

immunology Immunotherapy Industrial biotech Infectious disease Inflammatory disease influenza Insect-borne diseases

K

Kidney disease

L

Lab automation Liver disease lung cancer

M

Macular degeneration medical cannabis Medtech Melanoma menopause mental health issues Metabolic disorders Microbiome mitochondria Monoclonal antibodies mpox mRNA technology Multiple myeloma Multiple sclerosis Muscular dystrophy

N

Nanotechnology NASH Neurodegenerative disease Neurological disorders Next generation sequencing

O

Obesity omics Organoids Organs-on-chips osteoarthritis

P

Parkinson’s Peptides Phage therapy Precision medicine prostate cancer Protein psoriasis Psychiatric disorders

R

radiotherapy Rare disease Respiratory disease RNA technology RSV

S

Sexually Transmitted Diseases Skin disease Stem cells stroke surgery Sustainability Synthetic biology

T

T-cells thyroid transplants

V

Vaccines viruses

Z

Zika